Torrent Power Limited

Size: px
Start display at page:

Download "Torrent Power Limited"

Transcription

1 Absolute : ADD Torrent Power Limited Relative : Overweight 2QFY18 Update: Estimate ( ), TP ( ), Rating ( ) Spot Coverage 7% ATR in 9 months Steady cash generation to continue; higher demand key to swing in UNOSUGEN/DGEN profits Utilities 2017 Equirus All rights reserved Rating Information Price (Rs) 274 Target Price (Rs) 298 Target Date 31st Mar'19 Target Set On 7 th Nov 17 Implied yrs of growth (DCF) 15 Fair Value (DCF) 242 Fair Value (DDM) 45 Ind Benchmark BSE Power Model Portfolio Position LONG Stock Information Market Cap (Rs Mn) 85,165 Free Float (%) 46.4% 52 Wk H/L (Rs) 242/159 Avg Daily Volume (1yr) 897,710 Avg Daily Value (Rs Mn) Equity Cap (Rs Mn) 4,806 Face Value (Rs) 10 Bloomberg Code TPW IN Ownership Recent 3M 12M Promoters 53.6 % 0.0 % 0.0 % DII 18.4 % 0.3 % 0.3 % FII 6.4 % -0.2 % -0.2 % Public 21.6 % -0.1 % -0.1 % Price % 1M 3M 12M Absolute 25.2 % 36.0 % 53.5 % Vs Industry 22.8 % 38.1 % 37.9 % TATAPOWER 3.0 % 3.8 % 10.2 % CESC -5.5 % 0.7 % 65.1 % Consolidated Quarterly EPS Rs/Share 1Q 2Q 3Q 4Q EPS (16A) EPS (17A) Torrent Power (TPW) surprised positively with rising SUGEN PLFs and an all-round improvement across its Agra, Bhiwandi and renewable portfolios. Management remains optimistic on eventual adoption of the UNOSUGEN PPA by Gujarat Electricity Regulatory Commission (GERC). Rise in demand and gradual shutdown of older plants could lead to part/full revival of the 1.2GW DGEN plant. TPW s focus on renewable expansion and distribution capex would lead to a reduction in stranded gas-based plants/net fixed assets from 37% in FY17A to ~29% by FY20E. On SOTP basis, we arrive at a base case Mar 19 TP of Rs 298 (36%/40%/17% contribution from license area/power generation/ input based distribution) vs. a Mar 18 TP of Rs 243 earlier. However, further re-rating would be contingent upon resolution of UNOSUGEN and/or DGEN issues, and inorganic acquisitions. Revise to ADD (from LONG). Q2 benefits from ASG recoveries, rising SUGEN PLFs and better Agra/Bhiwandi/ renewable portfolios: The ASG circle continued to manage additional recoveries as per the mutli-year tariff (MYT) order. SUGEN operated at 71% PLFs and also sold 54 MUs in the exchange. Bhiwandi/Agra delivered a better performance with lower AT&C losses of 20%/19.5% vs. 23%/27% yoy. A higher renewable capacity base also contributed to the higher profit pool. Renewables, distribution franchisee and opportunistic generation acquisition - key cash deployment areas: TPW is set to generate Rs 18bn-20bn of cash in FY18E, and is looking to deploy this cash across renewables, distribution franchisee and in an opportunistic acquisition in the generation space. We are skeptical of renewable opportunities amidst the shift to competitive bidding in wind, and aggression in the solar space. We remain hopeful of TPW acquiring a stressed asset at lucrative valuations amidst pressure on lenders and promoters to resolve the issue. UNOSUGEN, DGEN - keys to a profit swing: We expect clarity on GERC s adoption of UNOSUGEN as a firm source of supply for Ahmedabad and Surat license areas by Mar 18E. DGEN could ramp up with rising base load demand and a growing base of renewables. We have factored 0%/35%/57% PLFs for both plants from FY18E/FY19E/FY20E. We expect losses related to these plants to swing from -Rs 6.9bn in FY18E to -Rs 2.5bn in FY19E, and to a profit of Rs. 1.9bn in FY20E. Valuation & view: TPW is trading at 1.8x FY18E P/B with 12%/11% RoEs in FY18E/FY19E, with a potential to generate >18% RoEs if UNOSUGEN and DGEN recover costs. Key risks could be reversal of LNG prices and low demand growth; key triggers would be govt. support for gas-based plants, GERC approval of UNOSUGEN tariffs, opportunistic acquisitions, scale-up at Dahej SEZ and addition of distribution franchisees. Revised Estimates % Change in Estimates FY18E FY19E FY18E FY19E Sales 104, , % -8.6% EBITDA 30,200 30, % -14.8% EBIT 19,274 19, % -19.2% Recurrin g PAT 3,911 8, % -21.0% EPS % -21.0% Consolidated Financials Rs. Mn YE Mar FY17A FY18E FY19E FY20E Sales 100, , , ,098 EBITDA 24,603 30,200 30,752 38,651 Depreciation 10,059 10,926 11,377 11,953 Interest Expense 10,580 10,301 10,682 11,138 Other Income 1,909 2,006 2,117 2,236 Reported PAT 4,234 8,635 8,627 14,286 Recurring PAT 3,013 3,911 8,250 13,804 Total Equity 68,921 74,966 81,004 91,005 Gross Debt 113, , , ,237 Cash 9,336 8,491 17,207 28,772 Rs Per Share FY17A FY18E FY19E FY20E Earnings Book Value Dividends FCFF P/E (x) P/B (x) EV/EBITDA (x) ROE (%) 6 % 12 % 11 % 17 % Core ROIC (%) 9 % 11 % 11 % 12 % EBITDA Margin (%) 24 % 29 % 25 % 27 % Net Margin (%) 3 % 4 % 7 % 10 % November 7, 2017 Analyst: Devam Modi devam@equirus.com ( ) Page 1 of 14 Before reading this report, you must refer to the disclaimer on the last page

2 Quarterly performance, consolidated % Change of 2QFY18 over 2QFY18 1QFY18 2QFY17 1QFY18 2QFY17 Net Sales 29,151 30,590 26,776-5% 9% Comments Cost of Power Purchased 8,968 10,117 9,234-11% -3% Fuel Cost 7,946 8,435 7,329-6% 8% Employee Cost 1,158 1,154 1,069 0% 8% Other Expenditure 2,703 2,933 2,565-8% 5% Total Expenditures 20,774 22,638 20,197-8% 3% EBITDA 8,377 7,952 6,579 5% 27% Depreciation 2,801 2,777 2,410 1% 16% EBIT 5,576 5,175 4,169 8% 34% Interest 2,131 2,101 2,643 1% -19% Other Income % 73% PBT 4,295 3,429 2,018 25% 113% Tax 1,079 1, % 75% PAT before MI & Associates 3,217 2,032 1,402 58% 129% Minority Interest Profit from Assoc Recurring PAT 3,217 2,032 1,402 58% 129% Extraordinaries Reported PAT 3,261 2,013 1,339 62% 143% EPS (Rs) % 140% EBITDA Margin 28.7% 26.0% 24.6% 274 bps 417 bps EBIT Margin 19% 17% 16% 221 bps 356 bps PBT Margin 15% 11% 8% 352 bps 720 bps PAT Margin 11% 7% 5% 460 bps 618 bps Tax Rate 25% 41% 31% bps -544 bps November 7, 2017 Analyst: Devam Modi devam@equirus.com ( ) Page 2 of 9

3 Valuation Snapshot Exhibit 1: Scenario Analysis: Power generation business the main swing factor at current levels, License area distribution remains core part of the business Segment Basis Valuation Rs./Share Remarks License Area Distribution 51, Ahmedabad, Surat and Gandhinagar P/B to RoE 51, Valued regulated equity of Rs 26.3bn at a P/B multiple of 1.86x based on consistent RoE of 18%+, cost of equity of 12% and growth of 5% Input based Franchise 23, Bhiwandi P/E 12, Expect gradual reduction in AT&C losses; valuing at 8x FY18 P/E now Agra P/E 11, Profitability to rise with further reduction in AT&C losses; considering valuation at 10x FY18E P/E now Power Generation 56, SUGEN P/B to RoE 25, Valued invested equity of Rs 9bn at a P/B multiple of 2.9x based on consistent RoEs of ~25%+, cost of equity of 12% and growth of 5% UNOSUGEN Distress 5, Considered 0.5x P/B given possibility of adoption by GERC DGEN Distress 8, Considered 0.0x P/B given low likelihood of near-term resolution but medium-term potential with higher demand Renewables P/B to RoE 17, MW of existing planned renewable capacities + further 360MW of projects expected by FY20E to cater to rising RPO requirements; expect 16%+ Equity IRR from these operations. Equity invested valued at 1.2x P/B Others 10, Torrent Power Grid P/B 1,800 4 Low downside risk to these valuations; steady annuity business Torrent Dahej P/E 1, x FY18E P/E of Torrent Energy Operations related to power distribution in Dahej SEZ Cash 7, Multiple of 1 to the cash and adjusted FY18E security deposits of Rs 10bn Bear Case Scenario [A] 97, Based on Rs 40bn debt write-offs related to UNOSUGEN and DGEN Base Case Scenario [B] 142, Based on 0.5x P/B for UNOSUGEN and 0x P/B for DGEN Bull Case Scenario [C] 162, Based on 1.0x P/B for UNOSUGEN and DGEN Source: Equirus Securities November 7, 2017 Analyst: Devam Modi devam@equirus.com ( ) Page 3 of 9

4 Company Snapshot How we differ from Consensus EPS Sales PAT - Equirus Consensus % Diff Comment FY17E 8.1 There is not much consensus estimate FY18E 17.2 available on the stock FY17E 104,233 FY18E 121,319 FY17E 4,234 FY18E 4,234 Our Key Investment arguments: Capital allocation to distribution and renewables on the rise+ NITI AAYOG support to gas based plants possible + Bhiwandi renewal and Agra improvements support core EPS + Outside chance of UNOSUGEN adoption by GERC Key Parameters Profitability Analysis FY17A FY18E FY19E FY20E License Area Distribution 4,298 7,833 3,582 3,757 Generation -3,326-2,873 1,576 6,488 Distribution Franchise 1,860 2,779 3,294 3,690 Others 1, Total 4,066 8,346 8,250 13,804 Risk to Our View Reversal in LNG prices and long-term non-availability of gas Key Triggers Further conviction in fuel security Sensitivity to Key Variables % Change % Impact on EPS PLF -5 % -8.2% Tariff -5 % -34.3% Fuel Costs 5 % -7.4 DCF Valuations & Assumptions Rf Beta Ke Term. Growth Debt/IC in Term. Yr 6.8 % % 2.0 % 59.1 % - FY18E FY19E FY20-22E FY23-27E FY27-31E Sales Growth 4 % 16 % 2 % 4 % 6 % NOPAT Margin 19 % 17 % 18 % 18 % 18 % IC Turnover RoIC 10.9 % 10.7 % 12.7 % 15.9 % 20.1 % Years of strong growth Valuation as on date (Rs) Valuation as of Mar' Based on DCF, assuming 15 years of 2% CAGR growth and 15% average ROIC, we derive our current fair value of Rs 232 and a 31 Mar 19 fair value of Rs 242. Company Description: Torrent Power is a power utility with a total of 3.67 GW power generation assets. This comprises 2.73 GW gas based plants MW coal based AMGEN +516 MW renewables. It is the license area distributor for Ahmedabad, Surat, Gandhinagar, and Dahej circles. It is also an input based distribution franchisee for Bhiwandi, Agra. It also has 3 major transmission lines comprising 1) 249 km 400 kv line from SUGEN to Ahmedabad, 2) multiple 220 kv lines from SUGEN to Surat and 3) 400 kv double circuit Comparable valuation Mkt Cap Price Target EPS P/E BPS P/B RoE Div Yield Company Reco. CMP Rs. Mn. Target Date FY17A FY18E FY19E FY17A FY18E FY19E FY17A FY18E FY17A FY18E FY19E FY17A FY18E Torrent Power Long , st Mar' % 12 % 11 % 2.0 % 1.3 % TATAPOWER NR ,631 NA NA % 4 % 8 % 1.6 % 1.3 % CESC NR ,536 NA NA % 7 % 6 % 1.0 % 0.7 % line from DGEN to Navsari. November 7, 2017 Analyst: Devam Modi devam@equirus.com ( ) Page 4 of 9

5 Mar/07 Sep/07 Mar/08 Sep/08 Mar/09 Sep/09 Mar/10 Sep/10 Mar/11 Sep/11 Mar/12 Sep/12 Mar/13 Sep/13 Mar/14 Sep/14 Mar/15 Sep/15 Mar/16 Sep/16 Mar/17 Sep/17 Mar/18 Sep/18 Mar/19 Mar/07 Sep/07 Mar/08 Sep/08 Mar/09 Sep/09 Mar/10 Sep/10 Mar/11 Sep/11 Mar/12 Sep/12 Mar/13 Sep/13 Mar/14 Sep/14 Mar/15 Sep/15 Mar/16 Sep/16 Mar/17 Sep/17 Mar/18 Sep/18 Mar/19 Consolidated Financials Torrent Power Absolute ADD Relative Overweight 7% ATR in 09 months P&L (Rs Mn) FY17A FY18E FY19E FY20E Balance Sheet (Rs Mn) FY17A FY18E FY19E FY20E Cash Flow (Rs Mn) FY17A FY18E FY19E FY20E Revenue 100, , , ,098 Equity Capital 4,806 4,806 4,806 4,806 PBT 5,873 10,980 10,811 17,796 Op. Expenditure 75,933 74,033 90, ,447 Reserve 64,115 70,160 76,198 86,198 Depreciation 10,059 10,926 11,377 11,953 EBITDA 24,603 30,200 30,752 38,651 Networth 68,921 74,966 81,004 91,005 Others Depreciation 10,059 10,926 11,377 11,953 Long Term Debt 82,700 85,398 90,038 88,754 Taxes Paid -1,576-2,345-2,184-3,510 EBIT 14,544 19,274 19,376 26,698 Def Tax Liability 31,127 31,744 32,106 32,483 Change in WC 4,641-6, Interest Expense 10,580 10,301 10,682 11,138 Minority Interest Operating C/F 18,998 12,718 19,678 25,852 Other Income 1,909 2,006 2,117 2,236 Account Payables 9,054 9,459 9,421 10,939 Capex -17,938-3,064-1,993 2,868 PBT 5,873 10,980 10,811 17,796 Other Curr Liabi 15,808 16,598 17,428 18,300 Change in Invest 3, Tax 1,576 2,345 2,184 3,510 Total Liabilities & Equity 207, , , ,480 Others PAT bef. MI & Assoc. 4,298 8,635 8,627 14,286 Net Fixed Assets 168, , , ,136 Investing C/F -24,919-13,996-13,377-9,093 Minority Interest Capital WIP 3,295 3,808 3,335 2,383 Change in Debt 2,495 3,314 5, Profit from Assoc Others 6,178 6,185 6,192 6,200 Change in Equity Recurring PAT 3,244 3,375 10,444 16,726 Inventory 3,694 3,427 3,989 4,705 Others 2,574 5,756 6,039 10,000 Extraordinaires 990 2, Account Receivables 9,751 8,567 9,971 11,761 Financing C/F 5,069 9,070 11,041 9,093 Reported PAT 4,234 6,219 10,444 16,726 Other Current Assets 7,612 17,102 16,253 16,524 Net change in cash -3, ,715 11,565 FDEPS (Rs) Cash 9,336 8,491 17,207 28,772 RoE (%) 6 % 12 % 11 % 17 % DPS (Rs) Total Assets 207, , , ,480 RoIC (%) 7 % 9 % 9 % 11 % CEPS (Rs) Non-cash Working Capital -3,805 3,038 3,364 3,751 Core RoIC (%) 9 % 11 % 11 % 12 % FCFPS (Rs) Cash Conv Cycle Div Payout (%) 61 % 20 % 20 % 20 % BVPS (Rs) WC Turnover P/E EBITDAM (%) 24 % 29 % 25 % 27 % FA Turnover P/B PATM (%) 4 % 8 % 7 % 10 % Net D/E P/FCFF Tax Rate (%) 27 % 21 % 20 % 20 % Revenue/Capital Employed EV/EBITDA Sales Growth (%) -14 % 4 % 16 % 18 % Capital Employed/Equity EV/Sales FDEPS Growth (%) -53 % 104 % 0 % 66 % Dividend Yield (%) 2.0 % 1.3 % 1.3 % 2.2 % TTM P/E vs. 2 yr forward EPS growth TTM P/B vs. 2 yr forward RoE EPS Growth RoE % % 200% 25x 4.0x % 20x x 20% % 15x x % x 10% 1.6x 200 0% % 5x 0.8x % - 0% November 7, 2017 Analyst: Devam Modi devam@equirus.com ( ) Page 5 of 9

6 Historical Consolidated Financials Torrent Power Absolute ADD Relative Overweight 7% ATR in 09 months P&L (Rs Mn) FY13A FY14A FY15A FY17A Balance Sheet (Rs Mn) FY13A FY14A FY15A FY16A Cash Flow (Rs Mn) FY13A FY14A FY15A FY16A Revenue 82,210 86, , ,536 Equity Capital 4,724 4,724 4,724 4,806 PBT 6,295 2,749 7,634 12,970 Op. Expenditure 68,703 73,979 83,161 75,933 Reserve 56,306 57,329 60,832 59,898 Depreciation 4,272 5,544 7,205 9,157 EBITDA 13,508 12,833 21,064 24,603 Networth 61,030 62,053 65,557 64,705 Others Depreciation 4,272 5,544 7,205 10,059 Long Term Debt 80,501 94,634 93,547 81,984 Taxes Paid EBIT 9,236 7,289 13,859 14,544 Def Tax Liability 13,858 18,642 20,161 29,349 Change in WC 17,982-23, Interest Expense 4,376 7,046 9,623 10,580 Minority Interest Operating C/F 25,020-16,941 10,188 15,652 Other Income 1,435 2,506 3,398 1,909 Account Payables 12,406 11,799 11,361 9,520 Capex PBT 6,295 2,749 7,634 5,873 Other Curr Liabi 4,673 3,832 5,392 10,295 Change in Invest Tax 2,426 1,670 3,777 1,576 Total Liabilities & Equity 172, , , ,153 Others PAT bef. MI & Assoc. 3,869 1,079 3,857 4,298 Net Fixed Assets 77, , , ,289 Investing C/F -24,599-6,729-30,519-16,943 Minority Interest Capital WIP 66,554 48,313 1,592 2,102 Change in Debt Profit from Assoc Others ,255 Change in Equity Recurring PAT 3,871 1,053 3,597 4,234 Inventory 2,446 2,902 2,597 4,202 Others Extraordinaires Account Receivables 7,561 8,036 8,924 10,570 Financing C/F 8,644 33,067 19,784-9,585 Reported PAT 3,871 1,053 3,597 4,234 Other Current Assets 3,759 5,907 6,211 5,879 Net change in cash 9,064 9, ,876 EPS (Rs) Cash 14,800 24,218 23,732 12,856 RoE (%) 7 % 2 % 6 % 14 % DPS (Rs) Total Assets 172, , , ,153 RoIC (%) 6 % 3 % 5 % 9 % CEPS (Rs) Non-cash Working Capital -3,313 1, Core RoIC (%) 6 % 5 % 8 % 13 % FCFPS (Rs) Cash Conv Cycle Div Payout (%) 29 % 28 % 24 % 29 % BVPS (Rs) WC Turnover P/E EBITDAM (%) 16 % 15 % 20 % 26 % FA Turnover P/B PATM (%) 5 % 1 % 3 % 8 % Net D/E P/FCFF Tax Rate (%) 39 % 61 % 49 % 30 % Revenue/Capital Employed EV/EBITDA Sales growth (%) 3 % 6 % 20 % 12 % Capital Employed/Equity EV/Sales FDEPS growth (%) -69 % -73 % 242 % 149 % Dividend Yield (%) 0.9 % 0.2 % 0.7 % 2.0 % November 7, 2017 Analyst: Devam Modi devam@equirus.com ( ) Page 6 of 9

7 Equirus Securities Research Analysts Sector/Industry Equity Sales Abhishek Shindadkar IT Services Vishad Turakhia Ashutosh Tiwari Auto, Metals & Mining Subham Sinha Depesh Kashyap Mid-Caps Sweta Sheth Devam Modi Power & Infrastructure Viral Desai Dhaval Dama FMCG, Mid-Caps Dealing Room Manoj Gori Consumer Durables Ashish Shah Maulik Patel Oil and Gas Ilesh Savla Praful Bohra Pharmaceuticals Manoj Kejriwal Rohan Mandora Banking & Financial Services Dharmesh Mehta Associates Sandip Amrutiya Ankit Choudhary Compliance Officer Bharat Celly Jay Soni Harshit Patel Corporate Communications Meet Chande Mahdokht Bharda Parva Soni Pranav Mehta Ronak Soni Samkit Shah Shreepal Doshi Varun Baxi Vikas Jain Rating & Coverage Definitions: Absolute Rating LONG : Over the investment horizon, ATR >= Ke for companies with Free Float market cap > Rs 5 billion and ATR >= 20% for rest of the companies ADD: ATR >= 5% but less than Ke over investment horizon REDUCE: ATR >= negative 10% but <5% over investment horizon SHORT: ATR < negative 10% over investment horizon Relative Rating OVERWEIGHT: Likely to outperform the benchmark by at least 5% over investment horizon BENCHMARK: likely to perform in line with the benchmark UNDERWEIGHT: likely to under-perform the benchmark by at least 5% over investment horizon Investment Horizon Investment Horizon is set at a minimum 3 months to maximum 18 months with target date falling on last day of a calendar quarter. Lite vs. Regular Coverage vs. Spot Coverage We aim to keep our rating and estimates updated at least once a quarter for Regular Coverage stocks. Generally, we would have access to the company and we would maintain detailed financial model for Regular coverage companies. We intend to publish updates on Lite coverage stocks only an opportunistic basis and subject to our ability to contact the management. Our rating and estimates for Lite coverage stocks may not be current. Spot coverage is meant for one-off coverage of a specific company and in such cases, earnings forecast and target price are optional. Spot coverage is meant to stimulate discussion rather than provide a research opinion. Registered Office: Equirus Securities Private Limited Unit No. 1201, 12th Floor, C Wing, Marathon Futurex, N M Joshi Marg, Lower Parel, Mumbai Tel. No: +91 (0) Fax No: +91- (0) Corporate Office: 3rd floor, House No. 9, Magnet Corporate Park, Near Zydus Hospital, B/H Intas Sola Bridge, S.G. Highway Ahmedabad Gujarat Tel. No: +91 (0) Fax No: +91 (0) November 7, 2017 Analyst: Devam Modi devam@equirus.com ( ) Page 7 of 9

8 2017 Equirus Securities Private Limited. All rights reserved. For Private Circulation only. This report or any portion hereof may not be reprinted, sold or redistributed without the written consent of Equirus Securities Private Limited Analyst Certification I, Devam Modi / Meet Chande, author to this report, hereby certify that all of the views expressed in this report accurately reflect my personal views about the subject company or companies and its or their securities. I also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Disclosures Equirus Securities Private Limited (ESPL) having Corporate Identification Number U65993MH2007PTC is registered in India with Securities and Exchange Board of India (SEBI) as a trading member on the Capital Market (Reg. No. INB ), Futures & Options Segment (Reg. No.INF ) of the National Stock Exchange of India Ltd. (NSE) and on Cash Segment (Reg. No.INB ) of Bombay Stock Exchange Limited (BSE).ESPL is also registered with SEBI as Research Analyst under SEBI (Research Analyst) Regulations, 2014 (Reg. No. INH ), as a Portfolio Manager under SEBI (Portfolio Managers Regulations, 1993 (Reg. No. INP ) and as a Depository Participant of the Central Depository Services (India) Limited (Reg. No. IN-DP ). There are no disciplinary actions taken by any regulatory authority against ESPL. ESPL is a subsidiary of Equirus Capital Pvt. Ltd. (ECPL) which is registered with SEBI as Category I Merchant Banker and provides investment banking services including but not limited to merchant banking services, private equity, mergers & acquisitions and structured finance. As ESPL and its associates are engaged in various financial services business, it might have: - (a) received compensation (except in connection with the preparation of this report) from the subject company for investment banking or merchant banking or brokerage services in the past twelve months;(b) managed or co-managed public offering of securities for the subject company in the past twelve months; or (c) have received a mandate from the subject company; or (d) might have other financial, business or other interests in entities including the subject company (ies) mentioned in this Report. ESPL & its associates, their directors and employees may from time to time have positions or options in the company and buy or sell the securities of the company (ies) mentioned herein. ESPL and its associates collectively do not own (in their proprietary position) 1% or more of the equity securities of the subject company mentioned in the report as the last day of the month preceding the publication of the research report. ESPL or its Analyst or Associates did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither ESPL nor Research Analysts have any material conflict of interest at the time of publication of this report. Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. ESPL has not been engaged in market making activity for the subject company. The Research Analyst engaged in preparation of this Report:- (a) has not received any compensation from the subject company in the past twelve months; (b) has not managed or co-managed public offering of securities for the subject company in the past twelve months; (c) has not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months; (d) has not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months; (e) has not received any compensation or other benefits from the subject company or third party in connection with the research report; (f) might have served as an officer, director or employee of the subject company; (g) is not engaged in market making activity for the subject company. This document is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject ESPL and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to a certain category of investors. Persons in whose possession of this document are required to inform themselves of, and to observe, such applicable restrictions. Please delete this document if you are not authorized to view the same. By reading this document you represent and warrant that you have full authority and all rights necessary to view and read this document without subjecting ESPL and affiliates to any registration or licensing requirement within such jurisdiction. This document has been prepared solely for information purpose and does not constitute a solicitation to any person to buy, sell or subscribe any security. ESPL or its affiliates are not soliciting any action based on this report. The information and opinions contained herein is from publicly available data or based on information obtained in good faith from sources believed to be reliable but ESPL provides no guarantee as to its accuracy or completeness. The information contained herein is as on date of this report, and is subject to change or modification and any such changes could impact our interpretation of relevant information contained herein. While we would endeavour to update the information herein on reasonable basis, ESPL and its affiliates, their directors and employees are under no obligation to update or keep the information current. Also there may be regulatory, compliance, or other reasons that may prevent ESPL and its group companies from doing so. This document is prepared for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document including the merits and risks involved. This document is intended for general circulation and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. ESPL and its group companies, employees, directors and agents accept no liability, and disclaim all responsibility, for the consequences of you or anyone else acting, or refraining to act, in reliance on the information contained in this publication or for any decision based on it. ESPL/its affiliates do and seek to do business with companies covered in its research report. Thus, investors should be aware that the firm may have conflict of interest. A graph of daily closing prices of securities is available at and (Choose a company from the list on the browser and select the three years period in the price chart). November 7, 2017 Analyst: Devam Modi devam@equirus.com ( ) Page 8 of 9

9 Disclosure of Interest statement for the subject Company Yes/No If Yes, nature of such interest Research Analyst or Relatives financial interest No Research Analyst or Relatives actual/beneficial ownership of 1% or more No Research Analyst or Relatives material conflict of interest No Disclaimer for U.S. Persons ESPL/its affiliates are not a registered broker dealer under the U.S. Securities Exchange Act of 1934, as amended (the 1934 act ) and under applicable state laws in the United States. In addition Equirus is not a registered investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the Acts ), and under applicable state laws in the United States. Accordingly, in the absence of specific exemption under the Acts, any brokerage and investment services provided by Equirus, including the products and services described herein are not available to or intended for U.S. persons. The information contained in this Report is not intended for any person who is a resident of the United States of America or a resident of any jurisdiction, the laws of which imposes prohibition on soliciting the securities business in that jurisdiction without going through the registration requirements and/ or prohibit the use of any information contained in this report. This Report and its respective contents do not constitute an offer or invitation to purchase or subscribe for any securities or solicitation of any investments or investment services and/or shall not be considered as an advertisement tool. "U.S. Persons" are generally defined as a natural person, residing in the United States or any entity organized or incorporated under the laws of the United States. US Citizens living abroad may also be deemed "US Persons" under certain rules. November 7, 2017 Analyst: Devam Modi devam@equirus.com ( ) Page 9 of 9

Lupin Ltd. Pharmaceuticals

Lupin Ltd. Pharmaceuticals 2017EquirusAll rights reserved Rating Information Price (Rs) 860 Target Price (Rs) 715 Target Date 31st Dec 18 Target Set On 07th Nov'17 Implied yrs of growth (DCF) 20 Fair Value (DCF) 824 Fair Value (DDM)

More information

Greaves Cotton Ltd. Standalone Estimate Revision:

Greaves Cotton Ltd. Standalone Estimate Revision: Greaves Cotton Ltd. Absolute : REDUCE Relative : UNDERWEIGHT 2QFY18 Result : Estimate (), TP (), Rating () Regular Coverage 2% Upside in 14months Changing industry dynamics to shake up key business verticals

More information

Cipla Ltd. Absolute : ADD Relative : Benchmark. 4QFY18 Result: Estimate ( ), TP ( ), Rating ( ) Regular Coverage 5% ATR in 16 Months

Cipla Ltd. Absolute : ADD Relative : Benchmark. 4QFY18 Result: Estimate ( ), TP ( ), Rating ( ) Regular Coverage 5% ATR in 16 Months 2018EquirusAll rights reserved Rating Information Price (Rs) 520 Target Price (Rs) 547 Target Date 30th Sep'19 Target Set On 22nd May'18 Implied yrs of growth (DCF) 20 Fair Value (DCF) 543 Fair Value (DDM)

More information

eclerx Services Ltd.

eclerx Services Ltd. 2017 Equirus All rights reserved Rating Information Price (Rs) 1,327 Target Price (Rs) 1,264 Target Date 31st Mar '18 Target Set On 13th Jan '17 Implied yrs of growth (DCF) 5 Fair Value (DCF) 1,174 Fair

More information

Wipro Ltd. Change in estimates: Revised Estimates % Change FY18E FY19E FY18E FY19E

Wipro Ltd. Change in estimates: Revised Estimates % Change FY18E FY19E FY18E FY19E 2017 Equirus All rights reserved Rating Information Price (Rs) 297 Target Price (Rs) 267 Target Date 31st Dec '18 Target Set On 17th Oct '17 Implied yrs of growth (DCF) 5 Fair Value (DCF) 270 Fair Value

More information

Cera Sanitaryware Ltd.

Cera Sanitaryware Ltd. 2016 Equirus All rights reserved Rating Information Price (Rs) 1,980 Target Price (Rs) 2,312 Target Date 30th Jun'17 Target Set On 5th May'16 Implied yrs of growth (DCF) 15 Fair Value (DCF) 2,215 Fair

More information

Bajaj Corp. Key risks: Lower than expected volume growth, increase in RM costs.

Bajaj Corp. Key risks: Lower than expected volume growth, increase in RM costs. 2017 Equirus All rights reserved Rating Information Price (Rs) 405 Target Price (Rs) 463 Target Date 30th Sep'18 Target Set On 13th July 17 Implied yrs of growth (DCF) 20 Fair Value (DCF) 388 Fair Value

More information

P&G Hygiene & Healthcare Ltd.

P&G Hygiene & Healthcare Ltd. 2017 Equirus All rights reserved Rating Information Price (Rs) 8,015 Target Price (Rs) 8,965 Target Date 30 Jun 18 Target Set On 14 Jun 17 Implied yrs of growth (DCF) 20 Fair Value (DCF) 8,965 Fair Value

More information

Solar Industries India

Solar Industries India Solar Industries India Absolute : ADD Relative : Overweight 4QFY18Result: Estimates(),PT(),Rating() Regular Coverage 9% ATR in 17 Months Strong 4Q led by international business; revise to ADD on earnings

More information

Gujarat Gas Ltd. 2QFY18 Results: Estimate ( ), TP ( ), Rating ( ) Volumes in line but margins disappoint on one-offs - downgrade to REDUCE

Gujarat Gas Ltd. 2QFY18 Results: Estimate ( ), TP ( ), Rating ( ) Volumes in line but margins disappoint on one-offs - downgrade to REDUCE Gujarat Gas Ltd. 2QFY18 Results: Estimate ( ), TP ( ), Rating ( ) Volumes in line but margins disappoint on one-offs - downgrade to REDUCE Regular Coverage Absolute: REDUCE Relative: Benchmark 5% Downside

More information

DB Corp Equirus All rights reserved Rating Information Price (Rs) 375 Target Price (Rs) 480 Target Date

DB Corp Equirus All rights reserved Rating Information Price (Rs) 375 Target Price (Rs) 480 Target Date DB Corp Absolute : LONG Relative : Overweight 1QFY18 Result: Estimate (), TP (), Rating () Regular Coverage 27% ATR in 14 Months Decent start to FY18, growth to accelerate in second half; retain LONG Media

More information

Domestic recovery on track, focus shifts on developing new brands upgrade to LONG on fair valuations Personal Care

Domestic recovery on track, focus shifts on developing new brands upgrade to LONG on fair valuations Personal Care Bajaj Corp Absolute : LONG Relative : Overweight 4QFY18 Result: Estimate ( ), TP ( ), Rating ( ) Regular Coverage 13% ATR in 14 Months Domestic recovery on track, focus shifts on developing new brands

More information

TeamLease Services. Ownership Recent 3M 12M Promoters 40.8 % 0.0 % -2.4 % DII 5.7 % 0.8 % -9.1 % FII 43.9 % 3.6 % 22.8 % Public 9.6 % -4.3 % -11.

TeamLease Services. Ownership Recent 3M 12M Promoters 40.8 % 0.0 % -2.4 % DII 5.7 % 0.8 % -9.1 % FII 43.9 % 3.6 % 22.8 % Public 9.6 % -4.3 % -11. TeamLease Services Absolute: LONG Relative: Overweight 2QFY19 Result: Est. ( ), PT ( ), Rating ( ) Regular Coverage 12% ATR in 17 months One step forward; Upgrade to LONG as valuations turn reasonable

More information

Maruti Suzuki India Limited

Maruti Suzuki India Limited Maruti Suzuki India Limited Absolute : LONG Relative : Overweight 4QFY18 Result: Estimate (),PT (), Rating () Regular Coverage 13% ATR in 14 Months Margins impacted by one-offs, to normalize from 1QFY19-

More information

Cadila Healthcare Ltd.

Cadila Healthcare Ltd. Cadila Healthcare Ltd. Absolute : Short Relative : Underweight Update Note: Estimate ( ), TP ( ), Rating ( ) Regular Coverage -7% ATR in 12 months USFDA raises concern in recently approved Sez facility

More information

Tata Consultancy Services

Tata Consultancy Services 2017 Equirus All rights reserved Rating Information Price (Rs) 2,446 Target Price (Rs) 2,434 Target Date 30th Sep '18 Target Set On 14th July 17 Implied yrs of growth (DCF) 15 Fair Value (DCF) 2,630 Fair

More information

Pokarna Ltd. Change in Estimates:

Pokarna Ltd. Change in Estimates: Pokarna Ltd. Absolute : LONG Relative : Overweight 3QFY16 Result : Estimate ( ), TP ( ), Rating ( ) Regular Coverage 57% ATR in 14 Months Stellar performance continues; Retain LONG as valuations are mouthwatering

More information

Persistent Systems Ltd.

Persistent Systems Ltd. 2017 Equirus All rights reserved Rating Information Price (Rs) 657 Target Price (Rs) 653 Target Date 30th Sep '18 Target Set On 23rd July 17 Implied yrs of growth (DCF) 5 Fair Value (DCF) 793 Fair Value

More information

Petronet LNG Ltd. Change in Estimates:

Petronet LNG Ltd. Change in Estimates: 217 Equirus All rights reserved Rating Information Price (Rs) 27 Target Price (Rs) Target Date 31st Mar'19 Target Set On 9th Nov'17 Implied yrs of growth (DCF) 2 Fair Value (DCF) Fair Value (DDM) 61 Ind

More information

Fiem Industries Limited

Fiem Industries Limited Fiem Industries Limited Absolute: LONG Relative: Overweight 1QFY19 Result: Estimate ( ), PT ( ), Rating ( ) Regular Coverage 85% ATR in 11 Months LED benefit visible in Sales growth, margin should normalize

More information

Strong sales momentum continues, however margins continue to remain at lower levels. Retain TRADE until clarity on margin improves

Strong sales momentum continues, however margins continue to remain at lower levels. Retain TRADE until clarity on margin improves 2016 Equirus All rights reserved Rating Information Price (Rs) 384 Target Price (Rs) 398 Target Date 30thSept 17 Target Set On 31stJuly'16 Implied yrs of growth (DCF) 20 Fair Value (DCF) 328 Fair Value

More information

Cera Sanitaryware Ltd.

Cera Sanitaryware Ltd. 2017 Equirus All rights reserved Rating Information Price (Rs) 3,322 Target Price (Rs) 3,538 Target Date 31st Mar'19 Target Set On 06th Nov'17 Implied yrs of growth (DCF) 15 Fair Value (DCF) 2,447 Fair

More information

Cadila Healthcare Ltd.

Cadila Healthcare Ltd. Cadila Healthcare Ltd. Absolute : Short Relative : Underweight 4QFY16 Results: Estimate (Ø), TP ( ), Rating ( ) Regular Coverage -8% ATR in 14 months Quarter Misses estimates; Muted earnings growth ahead

More information

Sterlite Technologies Ltd.

Sterlite Technologies Ltd. 218 Equirus All rights reserved Rating Information Price (Rs) 336 Target Price (Rs) 41 Target Date Target Set On Implied yrs of growth (DCF) 15 Fair Value (DCF) 441 Fair Value (DDM) 99 Ind Benchmark Model

More information

Lupin Ltd. Pharmaceuticals

Lupin Ltd. Pharmaceuticals 2018 Equirus All rights reserved Rating Information Price (Rs) 751 Target Price (Rs) 759 Target Date 31st Mar 19 Target Set On 15th May'18 Implied yrs of growth (DCF) 20 Fair Value (DCF) 708 Fair Value

More information

Minda Industries Equirus All rights reserved Rating Information Price (Rs) 1,284 Target Price (Rs) 1,449 Target Date

Minda Industries Equirus All rights reserved Rating Information Price (Rs) 1,284 Target Price (Rs) 1,449 Target Date Minda Industries Absolute : ADD Relative: Overweight 4QFY18 Result: Estimate (), TP (), Rating () Regular Coverage 10% ATR in 16 Months Earnings growth momentum to continue, strong play on premiumization

More information

Apex Frozen Foods Ltd

Apex Frozen Foods Ltd Apex Frozen Foods Ltd Absolute : LONG Relative : Overweight 2QFY19 Result: Estimate ( ), TP ( ), Rating ( ) Regular Coverage 53% ATR in 14 Months Valuations attractive even on conservative guidance maintain

More information

Kajaria Ceramics Ltd.

Kajaria Ceramics Ltd. Kajaria Ceramics Ltd. Absolute: LONG Relative: Benchmark 2QFY19 Result: Estimate ( ), TP ( ), Rating ( ) Regular Coverage 11% ATR in 17 months 2018 Equirus All rights reserved Rating Information Price

More information

Minda Industries Equirus All rights reserved Rating Information Price (Rs) 1,032 Target Price (Rs) 1,116 Target Date

Minda Industries Equirus All rights reserved Rating Information Price (Rs) 1,032 Target Price (Rs) 1,116 Target Date Minda Industries Absolute : ADD Relative Benchmark 2QFY18 Result: Estimate (), TP (), Rating () Regular Coverage 8% ATR in 14 Months Futuristic product portfolio to drive strong growth maintain ADD Auto

More information

Britannia Industries. Change in Estimates: Chg (%) FY17E Chg (%)

Britannia Industries. Change in Estimates: Chg (%) FY17E Chg (%) 2016 Equirus All rights reserved Rating Information Price (Rs) 2,634 Target Price (Rs) 3,546 Target Date 31 st Mar'17 Target Set On 11th Feb'16 Implied yrs of growth (DCF) 20 Fair Value (DCF) 2,292 Fair

More information

Gujarat Ambuja Exports

Gujarat Ambuja Exports Gujarat Ambuja Exports Absolute : LONG Relative : Overweight 4QFY18 Result: Estimate ( ), TP ( ), Rating ( ) Regular Coverage 31% ATR in 13 Months Focus shifts to profitable growth maintain LONG Agricultural

More information

Kajaria Ceramics Ltd.

Kajaria Ceramics Ltd. 2017 Equirus All rights reserved Rating Information Price (Rs) 676 Target Price (Rs) 714 Target Date 30th Sep'18 Target Set On 21st May'17 Implied yrs of growth (DCF) 15 Fair Value (DCF) 410 Fair Value

More information

Persistent Systems Ltd.

Persistent Systems Ltd. 2016 Equirus All rights reserved Rating Information Price (Rs) 666 Target Price (Rs) 645 Target Date 30th Sep '17 Target Set On 25th July '16 Implied yrs of growth (DCF) 5 Fair Value (DCF) 644 Fair Value

More information

Reliance Industries Ltd

Reliance Industries Ltd 217Equirus All rights reserved Rating Information Price (Rs) 996 Target Price (Rs) 1,45 Target Date Target Set On Implied yrs of growth (DCF) 15 Fair Value (DCF) 746 Fair Value (DDM) 1,43 Ind Benchmark

More information

lower realizations resulted in revenue growth of 9% yoy. Management during the AGM

lower realizations resulted in revenue growth of 9% yoy. Management during the AGM 2016EquirusAll rights reserved Rating Information Price (Rs) 1,922 Target Price (Rs) 2,147 Target Date 31stMar 17 Target Set On 31st July'16 Implied yrs of growth (DCF) 10 Fair Value (DCF) 1,509 Fair Value

More information

Jagran Prakashan Ltd. 2017EquirusAll rights reserved Rating Information Price (Rs) 173 Target Price (Rs) 200 Target Date

Jagran Prakashan Ltd. 2017EquirusAll rights reserved Rating Information Price (Rs) 173 Target Price (Rs) 200 Target Date Jagran Prakashan Ltd Absolute : LONG Relative : Overweight 3QFY18 Result: Estimate (), TP (), Rating () Regular Coverage 15% ATR in 14 Months Weak quarter but green shoots of recovery emerging - maintain

More information

Reliance Industries Ltd

Reliance Industries Ltd 216 Equirus All rights reserved Rating Information Price (Rs) 1,39 Target Price (Rs) 1,138 Target Date Target Set On Implied yrs of growth (DCF) 15 Fair Value (DCF) 1,18 Fair Value (DDM) 138 Ind Benchmark

More information

Wipro Ltd. Change in estimates: Revised Estimates % Change FY19E FY20E FY19E FY20E

Wipro Ltd. Change in estimates: Revised Estimates % Change FY19E FY20E FY19E FY20E 2018 Equirus All rights reserved Rating Information Price (Rs) 288 Target Price (Rs) 290 Target Date 31st Mar '19 Target Set On 25th Apr '18 Implied yrs of growth (DCF) 5 Fair Value (DCF) 253 Fair Value

More information

Wipro Ltd. Change in estimates:

Wipro Ltd. Change in estimates: 2018EquirusAll rights reserved Rating Information Price (Rs) 307 Target Price (Rs) 329 Target Date 31st Mar '20 Target Set On 24th Oct '18 Implied yrs of growth (DCF) 5 Fair Value (DCF) 298 Fair Value

More information

Finolex Industries Ltd.

Finolex Industries Ltd. Finolex Industries Ltd. Absolute: LONG Relative: OVERWEIGHT 2QFY19 Results: Estimates ( ), TP ( ), Rating ( ) Regular Coverage 24% ATR in 17 Months Beat driven by outperformance in PVC resin maintain LONG

More information

VIP IndustriesLtd. Change in Estimates: Rs. Mn FY19E Chg (%) FY20E Chg (%) Sales 17,916 4% 21,129 6% EBITDA 2,572-3% 3,109-1% EPS % 14.

VIP IndustriesLtd. Change in Estimates: Rs. Mn FY19E Chg (%) FY20E Chg (%) Sales 17,916 4% 21,129 6% EBITDA 2,572-3% 3,109-1% EPS % 14. VIP IndustriesLtd. Absolute : LONG Relative : BENCHMARK 2QFY19 Result: Estimate(), TP(), Rating() Regular Coverage 17% ATR in 14months Volume growth momentum continues, demand outlook stays robust upgrade

More information

Reliance Industries Ltd

Reliance Industries Ltd 217Equirus All rights reserved Rating Information Price (Rs) 1,13 Target Price (Rs) 1,188 Target Date Target Set On Implied yrs of growth (DCF) 15 Fair Value (DCF) 812 Fair Value (DDM) 221 Ind Benchmark

More information

Margin disappointment likely quarter-specific; mid/long-term prospects intact retain LONG

Margin disappointment likely quarter-specific; mid/long-term prospects intact retain LONG Finolex Cables Ltd. Absolute : LONG Relative : Overweight 2QFY19 Results: Estimate( ), TP( ),Rating( ) Regular Coverage 18% ATR in 17 months Margin disappointment likely quarter-specific; mid/long-term

More information

Graphite India Ltd. Estimate Revision:

Graphite India Ltd. Estimate Revision: Absolute : TRADE Relative : BENCHMARK 4QFY14 Results : Estimate ( ), TP ( ), Rating ( ) Regular Coverage 11% upside in 14 Months Strong free cash flows in FY14 led by 26% reduction in WC days Metals &

More information

Manpasand Beverages Ltd.

Manpasand Beverages Ltd. 2015 Equirus All rights reserved Rating Information Primary Issue Size (Rs. Bn) 4.0 Face value (Rs.) 10.0 Issue type 100% Book building Ownership Pre-Issue Post-Issue Promoters 67.2 % 50.4 % Others 32.8

More information

PSP Projects Limited SDB Project: A Marvel In The Making!

PSP Projects Limited SDB Project: A Marvel In The Making! S 2018 Equirus All rights reserved PSP Projects Limited SDB Project: A Marvel In The Making! Site Visit We recently visited PSP s Surat Diamond Bourse (SDB) project to get an update on its progress and

More information

Infosys Ltd. IT Services

Infosys Ltd. IT Services 2019 Equirus All rights reserved Rating Information Price (Rs) 684 Target Price (Rs) 757 Target Date 31st Mar '20 Target Set On 12th Jan '19 Implied yrs of growth (DCF) 20 Fair Value (DCF) 732 Fair Value

More information

Sadbhav Engineering Limited

Sadbhav Engineering Limited Absolute : LONG Sadbhav Engineering Limited Relative : Overweight 4QFY17 Result: Estimate (), Target (), Rating () Regular Coverage 20% ATR in 13 Months 2017 Equirus All rights reserved Rating Information

More information

PVR Ltd. Media & Entertainment

PVR Ltd. Media & Entertainment PVR Ltd Absolute : LONG Relative : Overweight 2QFY19 Result: Estimate ( ), TP ( ), Rating ( ) Regular Coverage 17% ATR in 17 Months SPI Cinemas to accelerate growth trajectory for PVR maintain LONG Media

More information

Century Plyboards India Ltd.

Century Plyboards India Ltd. z 218 Equirus All rights reserved Rating Information Price (Rs) 269 Target Price (Rs) 315 Target Date 3th Sep'19 Target Set On 6th Feb'18 Implied yrs of growth (DCF) 15 Fair Value (DCF) 231 Fair Value

More information

Avanti Feeds Ltd. Vote for Equirus at Asiamoney Broker Poll'18

Avanti Feeds Ltd. Vote for Equirus at Asiamoney Broker Poll'18 Avanti Feeds Ltd Absolute : LONG Relative : Overweight FY18 Annual report analysis Regular Coverage 65% ATR in 15 Months Near-term headwinds persist, but all priced in retain LONG Consumer Discretionary

More information

PNC Infratech Limited

PNC Infratech Limited Absolute : LONG PNC Infratech Limited Relative : Overweight 4QFY16 Result: Estimate ( ), Target ( ), Rating ( ) Regular Coverage 26% ATR in 13 Months 2016 Equirus All rights reserved Rating Information

More information

Operating metrics stable, marginal uptick in slippages retain ADD

Operating metrics stable, marginal uptick in slippages retain ADD HDFC Bank Absolute :ADD Relative : Equal Weight 1QFY18 Result: Est. ( ), Target ( ), Rating ( ) Regular Coverage 7.6% ATR in 14 months Operating metrics stable, marginal uptick in slippages retain ADD

More information

Karur Vysya Bank. Absolute: ADD Relative: Benchmark BFSI. Asset quality to remain under pressure; retain ADD

Karur Vysya Bank. Absolute: ADD Relative: Benchmark BFSI. Asset quality to remain under pressure; retain ADD 2017EquirusAll rights reserved Rating Information Price (Rs) 111 Target Price (Rs) 122 Target Date 31 st Mar 19 Target Set On 31 st Jan 18 Implied yrs of growth (ERE) 20 Fair Value (ERE) 122 Fair Value

More information

Equitas Holding. Absolute :REDUCE Relative : UNDERWEIGHT 1QFY18 Results: Est. ( ), Target ( ), Rating ( ) Regular Coverage 4% Downside in 14Months

Equitas Holding. Absolute :REDUCE Relative : UNDERWEIGHT 1QFY18 Results: Est. ( ), Target ( ), Rating ( ) Regular Coverage 4% Downside in 14Months Equitas Holding Absolute :REDUCE Relative : UNDERWEIGHT 1QFY18 Results: Est. ( ), Target ( ), Rating ( ) Regular Coverage 4% Downside in 14Months 2017Equirus All rights reserved Rating Information Price

More information

Cholamandalam Finance

Cholamandalam Finance Cholamandalam Finance Absolute: LONG Relative : OverWeight 4QFY18 Result: Est. ( ), Target ( ), Rating( ) Regular Coverage 16% ATR in 11 months Strong all-round performance; momentum to continue ahead

More information

BUY. At inflection point NTPC. Target Price: Rs 197. Key highlights. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E.

BUY. At inflection point NTPC. Target Price: Rs 197. Key highlights. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E. At inflection point Q2FY18 adjusted PAT grew 12% YoY at Rs 27 bn (vs. our estimate Rs 26 bn) in tandem with 17% YoY rise in regulated equity. Core RoE is still healthy at 20.2% though it contracted ~174

More information

Vadodara II PPA yet to be signed; TP revised upward to Rs126 on FY19x

Vadodara II PPA yet to be signed; TP revised upward to Rs126 on FY19x Gujarat Industries Power India Equity Research Power February 10, 2017 Result Update Emkay Your success is our success Vadodara II PPA yet to be signed; TP revised upward to Rs126 on FY19x CMP Target Price

More information

Cummins India Ltd Bloomberg Code: KKC IN

Cummins India Ltd Bloomberg Code: KKC IN Company Update Margins Under Pressure; Domestic Recovery Underway Half-yearly revenue was flat; margins were under pressure: Cummins India revenue, EBITDA and PAT for H1FY17 reached to Rs.24,784mn, Rs.4,649mn

More information

BHEL.BO BHEL IN. Structural story remains weak. Q1FY19 Result Update. Rating: REDUCE CMP: Rs72 TP: Rs73. July 25, 2018

BHEL.BO BHEL IN. Structural story remains weak. Q1FY19 Result Update. Rating: REDUCE CMP: Rs72 TP: Rs73. July 25, 2018 (BHEL IN) Rating: REDUCE CMP: Rs72 TP: Rs73 July 25, 2018 Q1FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY19E FY20E FY19E FY20E Rating REDUCE REDUCE Target Price

More information

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance RAMCO S HOLD Target Price: Rs 503 Deleveraging story playing out Ramco Cements total debt reduced by a massive Rs 5 bn to Rs 22 bn in FY16. The company generated total EBITDA of Rs 11.5 bn in FY16 and

More information

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights JK 20 NOV 2017 Quarterly Update BUY Target Price: Rs 1,220 White cement steals the show JK Cement s (JKCE) Q2FY18 EBITDA at Rs 2.1 bn (up 30% YoY) was higher than our and consensus estimates, mainly due

More information

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E RAMCO S BUY Target Price: Rs 435 Efforts on cost cutting paying off Q2 EBITDA at Rs 2.8 bn (up 30% YoY) was ahead of our estimates due to lower-than-expected costs. Average costs (excluding freight) declined

More information

Bayer Cropscience (BYRCS IN)

Bayer Cropscience (BYRCS IN) (BYRCS IN) Rating: ACCUMULATE CMP: Rs4,258 TP: Rs4,517 February 4, 2019 Q3FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY20E FY21E FY20E FY21E Rating ACCUMULATE

More information

Visaka Industries Ltd

Visaka Industries Ltd Company Update Superior Product Mix & New Age Markets to Aid Growth New investments to aid growth: Visaka continues to give a good set of numbers. YoY EPS grew at 142% aided by a revenue growth of 1.5%

More information

Larsen & Toubro (LT IN)

Larsen & Toubro (LT IN) (LT IN) Rating: BUY CMP: Rs1,321 TP: Rs1,566 July 25, 2018 Company Report Change in Estimates Target Reco Change in Estimates Current Previous FY19E FY20E FY19E FY20E Rating BUY BUY Target Price 1,566

More information

FY20E FY21E FY20E FY21E

FY20E FY21E FY20E FY21E (SJET IN) Rating: BUY CMP: Rs80 TP: Rs107 February 12, 2019 Q3FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY20E FY21E FY20E FY21E Rating BUY BUY Target Price

More information

BUY. Robust quarter with clear growth visibility DILIP BUILDCON. Target Price: Rs 610. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E

BUY. Robust quarter with clear growth visibility DILIP BUILDCON. Target Price: Rs 610. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E Robust quarter with clear growth visibility Dilip Buildcon s (DBL) Q1FY18 sales grew 60% YoY to Rs 16.6 bn, ahead of our estimate of Rs 12.0 bn and consensus of Rs 13.6 bn. EBITDA was up 47% at Rs 3.0

More information

Falling crude prices hit hard. Net sales ahead of estimates

Falling crude prices hit hard. Net sales ahead of estimates Change in Estimates Rating Target Falling crude prices hit hard BUY Sector: Oil & Gas Sector View: Neutral Analyst: Prayesh Jain research@indiainfoline.com Stock Data Sensex: 26,654 52 Week h/l (Rs): 330

More information

Simplex Infrastructures

Simplex Infrastructures May-14 Jul-14 Aug-14 Sep-14 Nov-14 Dec-14 Jan-15 Mar-15 Apr-15 May-15 India Research Infrastructure May 27, 2015 QUARTERLY REVIEW Bloomberg: SINF IN Reuters: SINF.BO HOLD Working capital ease to improve

More information

Cummins India. Growth/margin bottoming. Source: Company Data; PL Research

Cummins India. Growth/margin bottoming. Source: Company Data; PL Research Growth/margin bottoming May 25, 2018 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Shreyans Jain shreyansjain@plindia.com +91 22 66322256 Rating BUY Price Rs704 Target Price Rs928 Implied Upside 31.8%

More information

Sanghvi Movers Ltd. Results above estimates. Figure 1: Actual Vs Religare Estimates. Financial highlights. Valuations and Recommendation

Sanghvi Movers Ltd. Results above estimates. Figure 1: Actual Vs Religare Estimates. Financial highlights. Valuations and Recommendation Institutional Equity Research Key data 3 June 28 Sector Capital Goods Market Cap Rs9bn/US$.2bn 52 Wk H/L (Rs) 337/15.5 BSE Avg. daily vol. (6m) 4,437 BSE Code 5373 NSE Code SANGHVIMOV Bloomberg SGM IN

More information

Fineotex Chemical Ltd

Fineotex Chemical Ltd Company Update Decent Performance under Macroeconomic Pressure; Business Traction to Continue: Fineotex Chemical recorded decent set of result as consolidated sales grew by 1.1% YoY (largely in line) to

More information

Initiating Coverage. Uflex Ltd.

Initiating Coverage. Uflex Ltd. 2904 Recommendation CMP Target Price BUY Rs. 283 Rs. 444 Better times ahead! reported a good set of numbers for the year FY18 and for Q4. Sales for the quarter increase by 11.8% YoY to Rs 1809.8 Cr and

More information

SpiceJet. Healthy operating performance in Q2. Source: Company Data; PL Research

SpiceJet. Healthy operating performance in Q2. Source: Company Data; PL Research Healthy operating performance in Q2 November 28, 2016 Rohan Korde rohankorde@plindia.com +91 22 66322235 Rating BUY Price Rs65 Target Price Rs115 Implied Upside 76.9% Sensex 26,316 Nifty 8,114 (Prices

More information

Suzlon Energy Ltd RESULT UPDATE 16th August, 2017

Suzlon Energy Ltd RESULT UPDATE 16th August, 2017 RESULT UPDATE 16 th August, 2017 Aug-16 Oct-16 Dec-16 Feb-17 Apr-17 Jun-17 Aug-17 Please vote for us in Asiamoney Brokers Poll 2017: https://www.euromoney.com/article/b13j49qfcr6j pp/asiamoney-brokers-poll-2017-vote-now

More information

HCC BUY. Infrastructure April 10, QIP step in the right direction EVENT UPDATE. India Research. Bloomberg: HCC IN Reuters: HCNS.

HCC BUY. Infrastructure April 10, QIP step in the right direction EVENT UPDATE. India Research. Bloomberg: HCC IN Reuters: HCNS. Jan-14 Mar-14 Apr-14 May-14 Jul-14 Aug-14 Sep-14 Nov-14 Dec-14 Jan-15 India Research Infrastructure April 10, 2015 EVENT UPDATE Bloomberg: IN Reuters: HCNS.BO BUY QIP step in the right direction has successfully

More information

BHEL (BHEL IN) Weak execution and margins lead to the miss in earnings

BHEL (BHEL IN) Weak execution and margins lead to the miss in earnings INSTITUTIONAL EQUITY RESEARCH BHEL (BHEL IN) Weak execution and margins lead to the miss in earnings INDIA CAPITAL GOODS Quarterly Update 26 October 2018 Top takeaways from 2QFY19 BHEL s reported earnings

More information

All the more bullish, TP upgraded

All the more bullish, TP upgraded Sterlite Tech India Equity Research Small & Mid Cap April 18, 2017 Company Update Emkay Your success is our success All the more bullish, TP upgraded CMP Target Price Rs150 Rs208 ( ) Rating Upside BUY

More information

SSG continues to disappoint

SSG continues to disappoint Shoppers Stop SSG continues to disappoint India Equity Research Retail February 2, 2018 Result Update Refer to important disclosures at the end of this report Emkay Your success is our success CMP Target

More information

Key estimate revision. Financial summary. Year FY16E 29, % 3,583 2, FY17E 26, % 3,478 2,

Key estimate revision. Financial summary. Year FY16E 29, % 3,583 2, FY17E 26, % 3,478 2, : price: EPS: How does our one year outlook change? We maintain our negative stance on SKF India due to the absence of significant growth momentum drivers over the medium term. While railways could be

More information

Key estimate revision. Financial summary. Year

Key estimate revision. Financial summary. Year : price: EPS: How does our one year outlook change? We retain our positive outlook on WIL and believe that revival in MHCV industry, increasing content per vehicle and opportunity in exports would drive

More information

Amber Enterprises India Ltd

Amber Enterprises India Ltd 3QFY2019 Result Update Consumer Durable February 16, 2019 Amber Enterprises India Ltd Performance Update (` cr) 3QFY19 3QFY18 % yoy 2QFY19 % qoq Revenue 388.8 338.4 14.9 226.3 71.8 EBITDA 22.1 24.1 (8.2)

More information

Allcargo Logistics. Source: Company Data; PL Research

Allcargo Logistics. Source: Company Data; PL Research Slow capex continue to impact PES, weak show continues May 24, 2018 Keyur Pandya keyurpandya@plindia.com +912266322247 R Sreesankar rsreesankar@plindia.com +912266322214 Rating Accumulate Price Rs120 Target

More information

Kajaria Ceramics Ltd.

Kajaria Ceramics Ltd. Kajaria Ceramics Ltd. Annual Report Analysis Regular Coverage New launches to drive growth, gas prices & pricing stability remain key margin levers Building Materials 2018 Equirus All rights reserved Rating

More information

Adani Ports & SEZ Rating: Target price: EPS:

Adani Ports & SEZ Rating: Target price: EPS: Adani Ports & SEZ : price: EPS: Volume traction continues in a seasonally good quarter; maintain Adani Ports & SEZ reported a good quarter with total operating revenues (standalone) of Rs. 8.02bn and PAT

More information

Recovery to be gradual; Maintain HOLD

Recovery to be gradual; Maintain HOLD Dabur India Equity Research Consumers June 22, 2017 Company Update Refer to important disclosures at the end of this report Recovery to be gradual; Maintain HOLD Emkay Your success is our success CMP Target

More information

Jindal Steel & Power BUY. CMP Target Price `200 `320. 1QFY2019 Result Update Steel & Power. Performance Update

Jindal Steel & Power BUY. CMP Target Price `200 `320. 1QFY2019 Result Update Steel & Power. Performance Update Aug-15 Nov-15 Feb-16 May-16 Aug-16 Nov-16 Feb-17 May-17 Aug-17 Nov-17 Feb-18 May-18 Aug-18 1QFY2019 Result Update Steel & Power August 14, 2018 Jindal Steel & Power Performance Update INR Cr. Q1FY19 Q1FY18

More information

HOLD. Margins to improve from Q2 AMBUJA CEMENTS. Target Price: Rs 232. Other highlights

HOLD. Margins to improve from Q2 AMBUJA CEMENTS. Target Price: Rs 232. Other highlights AMBUJA S 4 MAY 2017 Quarterly Update HOLD Target Price: Rs 232 Margins to improve from Q2 Q1CY17standalone EBITDA at Rs 4.0 bn was in line withconsensus estimate.volume was up 3% YoY to 6 mnt. Realization

More information

Emkay. Demand environment remain weak. Century Plyboards. Result highlights. Slowdown in plywood segment impacted revenue growth

Emkay. Demand environment remain weak. Century Plyboards. Result highlights. Slowdown in plywood segment impacted revenue growth Century Plyboards India Equity Research Others January 29, 2016 Result Update Emkay Your success is our success Demand environment remain weak CMP Rs150 Target Price Rs166 ( ) Rating Upside ACCUMULATE

More information

Thermax. Source: Company Data; PL Research

Thermax. Source: Company Data; PL Research Near term outlook muted, working on building a strong base November 11, 2016 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Samir Bendre samirbendre@plindia.com +91 22 66322256 Rating Accumulate Price

More information

Emkay. Bonding strongly; Upgrade to BUY. Pidilite Industries. Stellar all-round show

Emkay. Bonding strongly; Upgrade to BUY. Pidilite Industries. Stellar all-round show Pidilite Industries India Equity Research Consumers February 3, 2016 Result Update Emkay Your success is our success Bonding strongly; Upgrade to BUY CMP Rs567 Target Price Rs670 ( ) Rating Upside BUY

More information

KDDL (KDDL IN) In expansion mode

KDDL (KDDL IN) In expansion mode INSTITUTIONAL EQUITY RESEARCH KDDL (KDDL IN) In expansion mode INDIA MIDCAP Quarterly Update Top takeaways from 2QFY19 Results in line, recovery in manufacturing & strong growth in precision engineering.

More information

Cummins India. Source: Company Data; PL Research

Cummins India. Source: Company Data; PL Research Technology leadership, cost optimization key focus October 28, 2016 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Samir Bendre samirbendre@plindia.com +91 22 66322256 Rating Accumulate Price Rs852

More information

FLASH NOTE Welspun India 31 Jan 17

FLASH NOTE Welspun India 31 Jan 17 Oct-11 Feb-12 Jun-12 Oct-12 Feb-13 Jun-13 Oct-13 Feb-14 Jun-14 Oct-14 Feb-15 Jun-15 Oct-15 Feb-16 Jun-16 Oct-16 Feb-17 FLASH NOTE Welspun India 31 Jan 17 CMP (Rs) 76 TP (Rs) 81 Outperformer Key Figures

More information

KEC International (KECI IN)

KEC International (KECI IN) (KECI IN) Rating: BUY CMP: Rs370 TP: Rs425 June 15, 2018 Analyst Meet Update Change in Estimates Target Reco Change in Estimates Current Previous FY19E FY20E FY19E FY20E Rating BUY - Target Price 425 -

More information

Music Broadcast BUY. Performance Update. CMP Target Price `293 `475. 3QFY2019 Result Update Media. Stock Info Sector Market Cap (Rs cr) Media

Music Broadcast BUY. Performance Update. CMP Target Price `293 `475. 3QFY2019 Result Update Media. Stock Info Sector Market Cap (Rs cr) Media Mar-17 May-17 Jul-17 Sep-17 Nov-17 Jan-18 Mar-18 May-18 Jul-18 Sep-18 Nov-18 Jan-19 3QFY2019 Result Update Media January 31, 2019 Music Broadcast Performance Update Y/E March (` cr) 3QFY19 3QFY18 % yoy

More information

BHEL SELL RESULTS REVIEW 1QFY15 13 AUG CMP (as on 12 Aug 2014) Rs 224 Target Price Rs 188

BHEL SELL RESULTS REVIEW 1QFY15 13 AUG CMP (as on 12 Aug 2014) Rs 224 Target Price Rs 188 RESULTS REVIEW 1QFY15 13 AUG 2014 BHEL SELL INDUSTRY CAPITAL GOODS CMP (as on 12 Aug 2014) Rs 224 Target Price Rs 188 Nifty 7,727 Sensex 25,881 KEY STOCK DATA Bloomberg/Reuters BHEL IN/BHEL.BO No. of Shares

More information

Equirus Infra & Industrial Conference

Equirus Infra & Industrial Conference Equirus Infra & Industrial Conference March, 2018 Devam Modi: Tel: +91-9099987467, devam@equirus.com /Maulik Patel: Tel +91-8128694110, maulik@equirus.com 1 Table of Contents Particulars No Key Takeaways

More information

Coal India. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research Earnings marred by weak realisations; Downgrade to Accumulate September 14, 2016 Kamlesh Bagmar kamleshbagmar@plindia.com +91 22 66322237 Ankit Shah ankitshah@plindia.com +91 22 66322244 Rating Accumulate

More information